Voloridge Investment Management
GH icon

Voloridge Investment Management’s Guardant Health GH Stock Holding History

Voloridge Investment Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-99,175
Closed -$10.1M – 1108
2025
Q4 		$10.1M Buy
+99,175
New +$8.87M 0.04% 577
2025
Q3 		– Sell
-173,441
Closed -$9.03M – 1250
2025
Q2 		$9.03M Sell
173,441
-877,380
-83% -$39.2M 0.03% 577
2025
Q1 		$44.8M Buy
1,050,821
+454,139
+76% +$19.6M 0.17% 174
2024
Q4 		$18.2M Sell
596,682
-65,585
-10% -$1.85M 0.06% 376
2024
Q3 		$15.2M Buy
662,267
+120,314
+22% +$3.41M 0.06% 453
2024
Q2 		$15.7M Sell
541,953
-618,850
-53% -$14.4M 0.06% 452
2024
Q1 		$23.9M Buy
1,160,803
+267,256
+30% +$5.73M 0.09% 286
2023
Q4 		$24.2M Sell
893,547
-54,385
-6% -$1.43M 0.1% 276
2023
Q3 		$28.1M Sell
947,932
-30,277
-3% -$1.06M 0.14% 205
2023
Q2 		$35M Sell
978,209
-66,324
-6% -$1.9M 0.17% 174
2023
Q1 		$24.5M Buy
1,044,533
+583,615
+127% +$16.7M 0.12% 245
2022
Q4 		$12.5M Buy
460,918
+430,335
+1,407% +$19.7M 0.07% 372
2022
Q3 		$1.65M Sell
30,583
-63,956
-68% -$3.28M 0.01% 1038
2022
Q2 		$3.81M Buy
94,539
+90,051
+2,006% +$4.46M 0.02% 777
2022
Q1 		$297K Buy
+4,488
New +$307K ﹤0.01% 1273
2021
Q4 		– Sell
-42,725
Closed -$5.34M – 1664
2021
Q3 		$5.34M Buy
42,725
+38,597
+935% +$4.59M 0.03% 653
2021
Q2 		$513K Buy
+4,128
New +$555K ﹤0.01% 1435
2021
Q1 		– Sell
-33,269
Closed -$4.29M – 1492
2020
Q4 		$4.29M Buy
+33,269
New +$3.83M 0.04% 497
2019
Q4 		– Sell
-29,038
Closed -$1.85M – 1185
2019
Q3 		$1.85M Buy
+29,038
New +$2.56M 0.03% 471

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Voloridge Investment Management's GH Position: Q1 2026 in Review

Voloridge Investment Management sold out of Guardant Health (GH) in Q1 2026, closing a stake of 99,175 shares — an estimated $10.1M sold.

Voloridge Investment Management first reported a position in GH in Q3 2019 and held it in 19 quarters. The position peaked at $44.8M in Q1 2025. 485 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Voloridge Investment Management reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 99,175 Guardant Health shares in Q1 2026, an estimated $10.1M.
  • Voloridge Investment Management first reported a position in Guardant Health in Q3 2019 and held it in 19 quarters.
  • Voloridge Investment Management's Guardant Health position peaked at $44.8M in Q1 2025.
  • 485 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.